BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 19632113)

  • 1. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
    Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of 7-alkene-3-quinolinecarbonitriles as Src kinase inhibitors.
    Boschelli DH; Wang D; Wang Y; Wu B; Honores EE; Barrios Sosa AC; Chaudhary I; Golas J; Lucas J; Boschelli F
    Bioorg Med Chem Lett; 2010 May; 20(9):2924-7. PubMed ID: 20363128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
    Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
    J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).
    Olsson H; Sjö P; Ersoy O; Kristoffersson A; Larsson J; Nordén B
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4738-40. PubMed ID: 20643547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design, synthesis and biological evaluation of 7-alkoxy-4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.
    Cao X; You QD; Li ZY; Liu XR; Xu D; Guo QL; Shang J; Chern JW; Chen ML
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6206-9. PubMed ID: 18930653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors.
    Berger DM; Dutia M; Powell D; Floyd MB; Torres N; Mallon R; Wojciechowicz D; Kim S; Feldberg L; Collins K; Chaudhary I
    Bioorg Med Chem; 2008 Oct; 16(20):9202-11. PubMed ID: 18815050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as dual inhibitors of Src and Abl kinases.
    Boschelli DH; Wang YD; Johnson S; Wu B; Ye F; Barrios Sosa AC; Golas JM; Boschelli F
    J Med Chem; 2004 Mar; 47(7):1599-601. PubMed ID: 15027848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles.
    Boschelli DH; Wu B; Ye F; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2006 Dec; 49(26):7868-76. PubMed ID: 17181170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.
    Golas JM; Lucas J; Etienne C; Golas J; Discafani C; Sridharan L; Boghaert E; Arndt K; Ye F; Boschelli DH; Li F; Titsch C; Huselton C; Chaudhary I; Boschelli F
    Cancer Res; 2005 Jun; 65(12):5358-64. PubMed ID: 15958584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Src kinase activity by 7-[(2,4-dichloro-5-methoxyphenyl)amino]-2-heteroaryl-thieno[3,2-b]pyridine-6-carbonitriles.
    Boschelli DH; Wu B; Barrios Sosa AC; Chen JJ; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4681-4. PubMed ID: 16125383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile preparation of new 4-phenylamino-3-quinolinecarbonitrile Src kinase inhibitors via 7-fluoro intermediates: identification of potent 7-amino analogs.
    Boschelli DH; Wu B; Ye F; Durutlic H; Golas JM; Lucas J; Boschelli F
    Bioorg Med Chem; 2008 Jan; 16(1):405-12. PubMed ID: 17905586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR studies on 4-anilino-3-quinolinecarbonitriles as Src kinase inhibitors using robust PCA and both linear and nonlinear models.
    Sun M; Zheng Y; Wei H; Chen J; Ji M
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1109-16. PubMed ID: 19555174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles.
    Boschelli DH; Wu B; Barrios Sosa AC; Durutlic H; Chen JJ; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2005 Jun; 48(11):3891-902. PubMed ID: 15916442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer.
    Lippa B; Kauffman GS; Arcari J; Kwan T; Chen J; Hungerford W; Bhattacharya S; Zhao X; Williams C; Xiao J; Pustilnik L; Su C; Moyer JD; Ma L; Campbell M; Steyn S
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3081-6. PubMed ID: 17398092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Src kinase activity by 7-ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of SKS-927.
    Boschelli DH; Barrios Sosa AC; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1358-61. PubMed ID: 17188862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The design, synthesis and anticancer activity of 4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS].
    Cao X; You QD; Li ZY; Guo QL; Yang Y; Shang J; Yan M; Chen JW; Chen ML
    Yao Xue Xue Bao; 2009 Mar; 44(3):288-95. PubMed ID: 19449526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity.
    Boschelli DH; Ye F; Wang YD; Dutia M; Johnson SL; Wu B; Miller K; Powell DW; Yaczko D; Young M; Tischler M; Arndt K; Discafani C; Etienne C; Gibbons J; Grod J; Lucas J; Weber JM; Boschelli F
    J Med Chem; 2001 Nov; 44(23):3965-77. PubMed ID: 11689083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Src kinase activity by 4-anilino-7-thienyl-3-quinolinecarbonitriles.
    Boschelli DH; Wang DY; Ye F; Yamashita A; Zhang N; Powell D; Weber J; Boschelli F
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2011-4. PubMed ID: 12113830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors.
    Zimmermann K; Wittman MD; Saulnier MG; Velaparthi U; Sang X; Frennesson DB; Struzynski C; Seitz SP; He L; Carboni JM; Li A; Greer AF; Gottardis M; Attar RM; Yang Z; Balimane P; Discenza LN; Lee FY; Sinz M; Kim S; Vyas D
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1744-8. PubMed ID: 20153189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of 2-methyl- and 2-amino-N-aryl-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amines as ring-constrained 2-anilino-4-(thiazol-5-yl)pyrimidine cyclin-dependent kinase inhibitors.
    McIntyre NA; McInnes C; Griffiths G; Barnett AL; Kontopidis G; Slawin AM; Jackson W; Thomas M; Zheleva DI; Wang S; Blake DG; Westwood NJ; Fischer PM
    J Med Chem; 2010 Mar; 53(5):2136-45. PubMed ID: 20146435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.